Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IDEAYA Biosciences (IDYA) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for IDEAYA Biosciences (IDYA) over the last 6 years, with Q4 2025 value amounting to 763.68%.

  • IDEAYA Biosciences' EBITDA Margin rose 11411200.0% to 763.68% in Q4 2025 from the same period last year, while for Dec 2025 it was 65.47%, marking a year-over-year increase of 38520600.0%. This contributed to the annual value of 51.32% for FY2025, which is 38662100.0% up from last year.
  • As of Q4 2025, IDEAYA Biosciences' EBITDA Margin stood at 763.68%, which was up 11411200.0% from 57.63% recorded in Q3 2025.
  • IDEAYA Biosciences' 5-year EBITDA Margin high stood at 57.63% for Q3 2025, and its period low was 1904.8% during Q4 2024.
  • For the 5-year period, IDEAYA Biosciences' EBITDA Margin averaged around 464.06%, with its median value being 336.04% (2023).
  • As far as peak fluctuations go, IDEAYA Biosciences' EBITDA Margin crashed by -10725000bps in 2024, and later soared by 11411200bps in 2025.
  • IDEAYA Biosciences' EBITDA Margin (Quarter) stood at 637.2% in 2021, then grew by 10bps to 573.6% in 2022, then plummeted by -45bps to 832.3% in 2023, then crashed by -129bps to 1904.8% in 2024, then soared by 60bps to 763.68% in 2025.
  • Its EBITDA Margin stands at 763.68% for Q4 2025, versus 57.63% for Q3 2025 and 1904.8% for Q4 2024.